[Long-term results of side-to-side and H-graft mesocaval shunt].
From January, 1966 to January, 1988, mesocaval shunt was performed on 47 patients with the variceal hemorrhage secondary to portal hypertension. Of these, 30 patients underwent side-to-side mesocaval shunt, the remaining 17 had H-graft mesocaval shunt. Postoperative follow-up averaged 6 years and 11 months for the patients surviving operation. The rebleeding rate was 21.1%, and the shunt related encephalopathy rate 25.5%. The 5-, 10-, 15- and 20-year survival rates of the whole series were 65.8%, 51.8%, 37.5% and 20.0% respectively. We conclude that mesocaval shunt is the procedure of choice for treatment of variceal bleeding, especially for the control of postoperatively recurrent variceal bleeding.
Cai
J X
JX
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D011170:Portasystemic Shunt, Surgical / Q000379:methods* / Q000401:mortality; D015996:Survival Rate